Smoking-associated bulky DNA adducts in bronchial tissue related to CYP1A1 MspI and GSTM1 genotypes in lung patients

Carcinogenesis
B SchoketI Vincze

Abstract

Relationships between smoking status and levels of bulky DNA adducts were investigated in bronchial tissue of lung patients in relation to their GSTM1 and CYP1A1 MspI genotypes. A total of 150 Hungarian patients undergoing pulmonary surgery were included in the study, 124 with lung malignancies and 26 with non-malignant lung conditions. There were significant relationships between smoking status and bulky DNA adduct levels, as determined by 32P-post-labelling analysis, in macroscopically normal bronchial tissues. There was a highly significant difference in the adduct levels of a combined group consisting of current smokers and short-term ex-smokers (< or = 1 year abstinence) compared with life-time non-smokers and long-term ex-smokers (> 1 year abstinence) (P = 0.0001). The apparent half-life was estimated to be 1.7 years for bulky DNA adducts in the bronchial tissue from ex-smokers. There were no statistically significant correlations between (i) daily cigarette dose and DNA adduct levels in current smokers, (ii) DNA adduct level and histological type of lung cancer, or (iii) GSTM1 and CYP1A1 MspI genotypes and DNA adduct levels after adjustment for either smoking status or malignancy. By multiple logistic regression analysis...Continue Reading

Citations

Jul 19, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Y W ChengH Lee
Jun 27, 2003·Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis & Ecotoxicology Reviews·Ya Wen Cheng, Huei Lee
Jun 14, 2008·Carcinogenesis·Emanuela Taioli
Apr 15, 1999·Journal of the National Cancer Institute·M R SpitzJ Di Giovanni
Oct 3, 2002·Journal of the National Cancer Institute·Peter G Shields
May 15, 2009·International Journal of Environmental Research and Public Health·Maura Lodovici, Elisabetta Bigagli
Aug 16, 2001·Pharmacogenetics·R W GodschalkF J Van Schooten
Apr 24, 2001·Environmental and Molecular Mutagenesis·W W AuM Y Heo
May 25, 2002·Journal of Internal Medicine·H KuperP Boffetta
Jan 1, 2001·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·R PastorelliL Airoldi
Mar 15, 2005·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Paolo VineisEmanuela Taioli
Nov 4, 2008·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Valentina GalloPaolo Vineis
Feb 21, 2003·International Journal of Cancer. Journal International Du Cancer·Paolo VineisEmanuela Taioli
Nov 5, 2011·International Journal of Cancer. Journal International Du Cancer·Mi-Sun LeeDavid C Christiani
Jan 25, 2003·Journal of Biochemistry and Molecular Biology·Roger W L GodschalkHelmut Bartsch
May 24, 2015·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Mi-Sun LeeDavid C Christiani
Mar 9, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Konstantinos P Economopoulos, Theodoros N Sergentanis
Jun 22, 2000·Toxicologic Pathology·A C Povey
Oct 4, 2002·Oncogene·Peter G Shields
Oct 16, 2002·Oncogene·John K Wiencke

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.